Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
1(10%)
Results Posted
11%(1 trials)

Phase Distribution

Ph phase_2
2
20%
Ph phase_3
1
10%
Ph not_applicable
2
20%
Ph phase_1
1
10%
Ph phase_4
4
40%

Phase Distribution

1

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution10 total trials
Phase 1Safety & dosage
1(10.0%)
Phase 2Efficacy & side effects
2(20.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
4(40.0%)
N/ANon-phased studies
2(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

10

all time

Status Distribution
Active(1)
Completed(9)

Detailed Status

Completed9
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (10.0%)
Phase 22 (20.0%)
Phase 31 (10.0%)
Phase 44 (40.0%)
N/A2 (20.0%)

Trials by Status

completed990%
recruiting110%

Recent Activity

1 active trials
Showing 5 of 10
recruitingphase_2

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

NCT07130786
completednot_applicable

Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers

NCT00221988
completednot_applicable

Effects of Levetiracetam (Keppra) on Alcohol Consumption

NCT01168687
completedphase_4

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

NCT00630968
completedphase_4

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

NCT00630357
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT07130786Phase 2

Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases

Recruiting
NCT00221988Not Applicable

Effects of Keppra on Thinking, Emotions, and Balance in Elderly Healthy Volunteers

Completed
NCT01168687Not Applicable

Effects of Levetiracetam (Keppra) on Alcohol Consumption

Completed
NCT00630968Phase 4

S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Completed
NCT00630357Phase 4

Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial Epilepsy

Completed
NCT00631150Phase 4

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

Completed
NCT00985348Phase 1

Human Pharmacology Study (Keppra Dry Syrup Bioequivalence Study)

Completed
NCT00223223Phase 4

Levetiracetam for Neuroprotection Against Corticosteroid-induced Hippocampal Dysfunction: A Proof of Concept Study

Completed
NCT00758277Phase 3

Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients

Completed
NCT00247364Phase 2

A Double Blind Crossover Trial of Levetiracetam (Keppra®) and Placebo in the Treatment of Restless Legs Syndrome (RLS)

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10